22.418 articles found

Methods for treatment of parkinson's disease

LUCA RUGGERO FARIELLO CATTANEO.

· 2004-04-08

Methods for treatment of Parkinson's Disease

CATTANEO CARLO, BENATTI LUCA, RUGGERO FARIELLO, SALVATI PATRICIA.

· 2004-04-08

METHODS FOR TREATMENT OF PARKINSON'S DISEASE

RUGGERO FARIELLO, CATTANEO CARLO, BENATTI LUCA, SALVATI PATRICIA.

· 2004-04-08

METHODS FOR TREATMENT OF PARKINSON'S DISEASE

RUGGERO FARIELLO, CATTANEO CARLO, SALVATI PATRICIA, BENATTI LUCA.

· 2004-04-08

PHARMACEUTICAL COMPOSITION CONTAINING LEVODOPA AND CARBIDOPA

TAGLIAMONTE Alessandro.

· 2004-04-06

Pharmaceutical composition containing levodopa and carbidopa

TAGLIAMONTE ALESSANDRO.

· 2004-04-06

Delivery of compounds for the treatment of Parkinsons through an inhalation route

RABINOWITZ JOSHUA D, ZAFFARONI ALEJANDRO C.

· 2004-04-01

Delivery of compounds for the treatment of Parkinsons through an inhalation route

RABINOWITZ JOSHUA D, ZAFFARONI ALEJANDRO C.

· 2004-04-01

Delivery of compounds for the treatment of parkinsons through an inhalation route

RABINOWITZ JOSHUA D, ZAFFARONI ALEJANDRO C.

· 2004-04-01

Delivery of compounds for the treatment of parkinsons through an inhalation route

RABINOWITZ JOSHUA D, ZAFFARONI ALEJANDRO C.

· 2004-04-01

Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.

Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E.

Exp Neurol · 2004-04-01

DOI: 10.1016/s0014-4886(03)00342-xPMID: 15026254

Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease.

Scholz J, Klingemann I, Moser A.

J Neurol Neurosurg Psychiatry · 2004-04-01

DOI: 10.1136/jnnp.2003.010769PMID: 15026514